Development and investigation of gastro retentive dosage form of weakly basic drug

Samip S Shah, Shridhar J Pandya1, Mahesh K Waghulade

Abstract


The release of drug substance from controlled-release dosage forms is often pH-dependent since most drugs are either weak acids or weak bases. A system that permits the drug release to be changed freely while maintaining pH-independent drug release (model drug was Domperidone) was developed. Powder mixture of drug and HPMC K4M, eudragit L100, sodium bicarbonate (as gas-generating agent) and other excipients were mixed and directly compressed using single-punch tablet compression machine. It was found that sodium bicarbonate reacts with HCl and produce carbon dioxide which creates pores in tablet and elevates swelling by wetting the polymer. So it helps in maintaining the buoyancy. The release rate could be modified by varying the polymer ratio. The prepared tablets were evaluated for general appearance, content uniformity, hardness, friability, buoyancy, in vitro drug release and in vivo studies.The best formulation (D1) was selected based on in vitro characteristics and was used in vivo radiographic studies by incorporating BaSO4. These studies revealed that the
tablets remained in the stomach for 250630 min in fasted rabbits and indicated that gastric retention time was increased by the floating principle, which was considered desirable for the absorption window drugs. The linear regression analysis and model fitting showed that all these formulations followed Higuchi model, which had a higher value of correlation coefficient(r). The scanning electron microscopy images of the tablet (D1 formulation) were taken before and after dissolution and images showed that the drug was released from matrix by diffusion mechanism. Stability studies of all formulations were
carried out at elevated temperature and humidity conditions of 4062oC/7565% RH and a control sample was placed at an ambient condition for 12 months. It was found that there was no significant change in buoyancy property as well as in drug
content from initial drug content of all the formulations at the end of 12 months, indicating that the formulations are stable.


Full Text:

PDF

References


Patel A, Modasiya M, Shah D, Patel V. Development and in vivo

floating behavior of verapamil HCl intragastric floating tablets. AAPS

PharmSciTech 2009;10:310-5.

Prajapati ST, Patel LD, Patel DM. Gastric floating matrix tablets:

Design and optimization using combination of polymers. Acta Pharm

;58:221-9.

Shweta A, Ali J, Ahuja A, Roop KK, Sanjula B. Floating drug delivery

system: A review. J Control Rel 2005;112-6.

Bardonnet PL, Falvre V, Pagh WJ, Piffaretti JC, Falson F. Gastro retentive

dosage forms: Overview and special case of Helicobacter pylori. J Control

Rel 2006;111:1-18.

Shirwaikar AA, Kumar SM, Jacob S, Rashi W, Ravi K. Recent developments in floating drug delivery systems for gastric retention of drugs: An overview. Indian Drugs 2006;43:697-703.

Choudhur y A, Das S, Bahadur S, Saha S. Development and

characterization extended release gastro retentive drug delivery.

Journal of pharmacy research 2009;2(10);1557-60.

Robinson JR, Lee VH. Controlled drug delivery. 2nd ed. New York: Marcel

Dekker Inc; 1987. p. 42-3.

Liebermann Ha, Lachman L, Kanig JL. The theory and practice of

industrial pharmacy. 3rd ed. Varghese Publishing House; 1990. p. 253-96.

British Pharmacopoeia. HMSO; London: Domperidone tablets

monograph; 2004. p. 1.

Rosa M, Zia H, Rhodes T. Dosing and testing in vitro of a bioadhesive

and a floating drug delivery system for oral application. Int J Pharm

;105:65-70.

Gohel MC, Mehta PR, Dave PK, Bariya NH. More relevant dissolution

method for evaluation of FDDS. Dissolution Technol 2005;11:22-5.

Reddy KR, Mutalik S, Reddy S. Once-daily sustained release matrix

tablets of Nicorandil: Formulation and in vitro evaluation. AAPS Pharm

Sci Tech 2003;4:61.

Bomma R, Naidu RS, Yamsani MR, Veerbrahma K. Development and

evaluation of gastro retentive norfloxacin floating tablets. Acta Pharm

;59:211-21.

Nama M, Gonugunta CR, Veerareddy PR. Formulation and evaluation of

gastro retentive dosage forms of clarithromycin. AAPS PharmSciTech

;9:231-7.




DOI: http://dx.doi.org/10.22377/ajp.v4i1.117

Refbacks

  • There are currently no refbacks.